NCT05977478 Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous Lesions Status UNKNOWN Phase NA
NCT05975749 Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer Status RECRUITING Phase PHASE2
NCT05974410 Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Status AVAILABLE Phase N/A
NCT05969444 Endoscopic Surveillance on a High-risk Population for Gastric Cancer in Latin America: The ECHOS Cohort Study. Status COMPLETED Phase N/A
NCT05966246 The Effect of Prucalopride Succinate on Gastrointestinal Motility After Laparoscopic Gastrectomy : Prospective Double Blind Case-control Study Status COMPLETED Phase NA
NCT05956847 The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric Status RECRUITING Phase N/A
NCT05955833 89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study Status UNKNOWN Phase PHASE1
NCT05952375 Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial Status UNKNOWN Phase NA
NCT05948449 To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Status UNKNOWN Phase PHASE2
NCT05930860 Efficacy and Safety of ESD for the Treatment of Superficial Gastric Neoplasms Status RECRUITING Phase N/A
NCT05928897 Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab Status UNKNOWN Phase PHASE2
NCT05928819 Evaluation of a Computer-aided Diagnosis System (CADx) in the Early Detection of Gastric Cancer in France. Cancer in France. Status UNKNOWN Phase N/A
NCT05924789 Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America Status COMPLETED Phase N/A
NCT05918094 Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma Status RECRUITING Phase PHASE3
NCT05914610 Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT05901779 Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Status UNKNOWN Phase NA
NCT05901376 MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection Status UNKNOWN Phase N/A